Pseudoprogression of extramedullary lesions during elranatamab therapy in relapsed or refractory multiple myeloma
Journal of Clinical and Experimental Hematopathology · 2026 · 66 (1) · 63-68
DOI: 10.3960/jslrt.25065 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2026. Verfasst von Akihiro Kawatsuki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Himeji-shi, Hyogo, Japan. Hauptthemen laut MEDLINE: Multiple Myeloma, Antibodies, Bispecific. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Himeji-shi, Hyogo, Japan.
- Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
- Department of Pathology, Japanese Red Cross Society Himeji Hospital, Himeji-shi, Hyogo, Japan.
Zitieren
APA
Kawatsuki, A., Kobayashi, H., Kimura, S., Fushimi, S., Doi, Y., Fujiwara, Y., Yamasaki, T., Asano, T., & Hiramatsu, Y. (2026). Pseudoprogression of extramedullary lesions during elranatamab therapy in relapsed or refractory multiple myeloma. Journal of Clinical and Experimental Hematopathology, 66(1), 63-68. https://doi.org/10.3960/jslrt.25065
Vancouver
Kawatsuki A, Kobayashi H, Kimura S, Fushimi S, Doi Y, Fujiwara Y, et al. Pseudoprogression of extramedullary lesions during elranatamab therapy in relapsed or refractory multiple myeloma. Journal of Clinical and Experimental Hematopathology. 2026;66(1):63-68. doi:10.3960/jslrt.25065
BibTeX
@article{Kawatsuki2026,
author = {Kawatsuki, Akihiro and Kobayashi, Hiroki and Kimura, Shoka and Fushimi, Soichiro and Doi, Yuki and Fujiwara, Yuki and Yamasaki, Tomoko and Asano, Takeru and Hiramatsu, Yasushi},
title = {Pseudoprogression of extramedullary lesions during elranatamab therapy in relapsed or refractory multiple myeloma},
journal = {Journal of Clinical and Experimental Hematopathology},
year = {2026},
volume = {66},
number = {1},
pages = {63--68},
doi = {10.3960/jslrt.25065}
}
EUVIMED